Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Addus HomeCare Corp (ADUS)

Anderson Darby — EVP, Chief Govt Rel Officer
Feb 24, 2026
Sale
Shares
733
Price
$106.98
Total Value
$78.42K
Shares Held After
46,642
% of Holdings
1.5%

Addus HomeCare Corp (ADUS)

Stevenson Roberton James — EVP, Chief HR Officer
Feb 24, 2026
Sale
Shares
567
Price
$107.35
Total Value
$60.87K
Shares Held After
14,314
% of Holdings
3.8%

Addus HomeCare Corp (ADUS)

WATTENBARGER MICHAEL D. — EVP, Chief Information Officer
Feb 24, 2026
Sale
Shares
592
Price
$107.35
Total Value
$63.55K
Shares Held After
9,744
% of Holdings
5.7%

Addus HomeCare Corp (ADUS)

RAINES MONICA — EVP, CCO and Quality Officer
Feb 24, 2026
Sale
Shares
437
Price
$106.99
Total Value
$46.75K
Shares Held After
14,020
% of Holdings
3.0%

Addus HomeCare Corp (ADUS)

TUCKER DAVID W. — EVP, Chief Strategy Officer
Feb 24, 2026
Sale
Shares
704
Price
$107.35
Total Value
$75.57K
Shares Held After
10,802
% of Holdings
6.1%

Voyager Therapeutics, Inc. (VYGR)

Carter Todd Alfred — Chief Scientific Officer
Feb 24, 2026
Sale
Shares
4,174
Price
$3.76
Total Value
$15.69K
Shares Held After
145,718
% of Holdings
2.8%
Feb 24, 2026
Sale
Shares
6,458
Price
$3.77
Total Value
$24.35K
Shares Held After
199,738
% of Holdings
3.1%
Feb 24, 2026
Sale
Shares
14,197
Price
$3.79
Total Value
$53.81K
Shares Held After
484,060
% of Holdings
2.8%

Voyager Therapeutics, Inc. (VYGR)

Jorgensen Nathan D. — Chief Financial Officer
Feb 24, 2026
Sale
Shares
4,668
Price
$3.77
Total Value
$17.60K
Shares Held After
151,416
% of Holdings
3.0%

LABCORP HOLDINGS INC. (LH)

Caveney Brian J — EVP, Pres of ED, CMO & CSO
Feb 24, 2026
Sale
Shares
1,500
Price
$286.31
Total Value
$429.46K
Shares Held After
30,107
% of Holdings
4.7%

EXAGEN INC. (XGN)

Black Jeffrey G. — Chief Financial Officer
Feb 24, 2026
Sale
Shares
1,584
Price
$3.61
Total Value
$5.72K
Shares Held After
267,442
% of Holdings
0.6%

EXAGEN INC. (XGN)

ABALLI JOHN — Director
Feb 24, 2026
Sale
Shares
11,430
Price
$3.61
Total Value
$41.26K
Shares Held After
702,997
% of Holdings
1.6%

CODEXIS, INC. (CDXS)

Lutz Stefan — Chief Scientific Officer
Feb 24, 2026
Sale
Shares
5,862
Price
$1.13
Total Value
$6.64K
Shares Held After
130,421
% of Holdings
4.3%

iRhythm Holdings, Inc. (IRTC)

Rosenbaum Marc Wade — Chief Accounting Officer
Feb 24, 2026
Sale
Shares
280
Price
$140.91
Total Value
$39.45K
Shares Held After
10,601
% of Holdings
2.6%

iRhythm Holdings, Inc. (IRTC)

Smith Mervin — EVP Strategic Business Ops
Feb 24, 2026
Sale
Shares
732
Price
$140.91
Total Value
$103.15K
Shares Held After
15,106
% of Holdings
4.6%

ARTIVION, INC. (AORT)

Davis John E — Chief Commercial Officer
Feb 24, 2026
Sale
Shares
2,075
Price
$35.69
Total Value
$74.06K
Shares Held After
188,868
% of Holdings
1.1%

ARTIVION, INC. (AORT)

Horton Amy — VP, Chief Accounting Officer
Feb 24, 2026
Sale
Shares
830
Price
$35.69
Total Value
$29.63K
Shares Held After
127,497
% of Holdings
0.6%

ARTIVION, INC. (AORT)

Stanton Marshall S. — SVP, Clinical & MD Affair
Feb 24, 2026
Sale
Shares
1,259
Price
$35.69
Total Value
$44.94K
Shares Held After
41,921
% of Holdings
2.9%

ARTIVION, INC. (AORT)

Mackin James P — President & CEO
Feb 24, 2026
Sale
Shares
13,936
Price
$35.69
Total Value
$497.42K
Shares Held After
766,095
% of Holdings
1.8%

ARTIVION, INC. (AORT)

Berry Lance A — EVP, COO, CFO & Treasurer
Feb 24, 2026
Sale
Shares
4,485
Price
$35.69
Total Value
$160.08K
Shares Held After
143,965
% of Holdings
3.0%

ARTIVION, INC. (AORT)

Holloway Jean F — SVP, General Counsel
Feb 24, 2026
Sale
Shares
1,668
Price
$35.69
Total Value
$59.54K
Shares Held After
152,203
% of Holdings
1.1%

Ceribell, Inc. (CBLL)

Foehr David — Senior VP, Finance and PAO
Feb 24, 2026
Sale
Shares
781
Price
$19.98
Total Value
$15.60K
Shares Held After
17,550
% of Holdings
4.3%

Cullinan Therapeutics, Inc. (CGEM)

SUMER JACQUELYN L — Chief Legal Officer
Feb 24, 2026
Sale
Shares
3,601
Price
$14.47
Total Value
$52.11K
Shares Held After
128,089
% of Holdings
2.7%

Cullinan Therapeutics, Inc. (CGEM)

Jones Jeffrey Alan — Chief Medical Officer
Feb 24, 2026
Sale
Shares
4,582
Price
$14.47
Total Value
$66.30K
Shares Held After
159,968
% of Holdings
2.8%

Cullinan Therapeutics, Inc. (CGEM)

Michaelson Jennifer — Chief Scientific Officer
Feb 24, 2026
Sale
Shares
3,601
Price
$14.47
Total Value
$52.11K
Shares Held After
176,624
% of Holdings
2.0%
Feb 24, 2026
Sale
Shares
103,526
Price
$3.66
Total Value
$378.91K
Shares Held After
1,489,002
% of Holdings
6.5%
Feb 24, 2026
Sale
Shares
13,515
Price
$14.47
Total Value
$195.56K
Shares Held After
390,803
% of Holdings
3.3%

IRONWOOD PHARMACEUTICALS INC (IRWD)

Gaskins Tammi L — Chief Commercial Officer
Feb 24, 2026
Sale
Shares
11,239
Price
$3.66
Total Value
$41.13K
Shares Held After
213,738
% of Holdings
5.0%

IRONWOOD PHARMACEUTICALS INC (IRWD)

Silver Ronald — Principal Accounting Officer
Feb 24, 2026
Sale
Shares
12,621
Price
$3.66
Total Value
$46.19K
Shares Held After
252,636
% of Holdings
4.8%
Feb 24, 2026
Purchase
Shares
20,000
Price
$1.00
Total Value
$19.95K
Shares Held After
1,908,551
% of Holdings
1.0%

IRONWOOD PHARMACEUTICALS INC (IRWD)

John Minardo — Chief Legal Officer
Feb 24, 2026
Sale
Shares
19,053
Price
$3.66
Total Value
$69.73K
Shares Held After
363,886
% of Holdings
5.0%

ARDELYX, INC. (ARDX)

RAAB MICHAEL — Director
Feb 24, 2026
Sale
Shares
41,666
Price
$6.25
Total Value
$260.62K
Shares Held After
1,836,153
% of Holdings
2.2%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Feb 24, 2026
Sale
Shares
15,771
Price
$156.53
Total Value
$2.47M
Shares Held After
51,871
% of Holdings
23.3%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Feb 24, 2026
Sale
Shares
4,151
Price
$155.06
Total Value
$643.65K
Shares Held After
67,642
% of Holdings
5.8%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Feb 24, 2026
Sale
Shares
4,852
Price
$153.93
Total Value
$746.87K
Shares Held After
71,793
% of Holdings
6.3%

IRONWOOD PHARMACEUTICALS INC (IRWD)

Martini Gregory S. — Chief Financial Officer
Feb 24, 2026
Sale
Shares
11,457
Price
$3.66
Total Value
$41.93K
Shares Held After
160,601
% of Holdings
6.7%

Caribou Biosciences, Inc. (CRBU)

Kelly Timothy P — Chief Technology Officer
Feb 24, 2026
Sale
Shares
3,147
Price
$1.96
Total Value
$6.17K
Shares Held After
79,353
% of Holdings
3.8%

Caribou Biosciences, Inc. (CRBU)

Khan Ruhi Ahmad — Chief Business Officer
Feb 24, 2026
Sale
Shares
6,938
Price
$1.96
Total Value
$13.60K
Shares Held After
104,998
% of Holdings
6.2%

Caribou Biosciences, Inc. (CRBU)

MCCLUNG BARBARA G — Chief Legal Officer
Feb 24, 2026
Sale
Shares
6,938
Price
$1.96
Total Value
$13.60K
Shares Held After
481,564
% of Holdings
1.4%

Caribou Biosciences, Inc. (CRBU)

Albertson Tina M. — Chief Medical Officer
Feb 24, 2026
Sale
Shares
1,066
Price
$1.96
Total Value
$2.09K
Shares Held After
68,523
% of Holdings
1.5%
Feb 24, 2026
Sale
Shares
736
Price
$18.15
Total Value
$13.36K
Shares Held After
325,059
% of Holdings
0.2%

SERA PROGNOSTICS, INC. (SERA)

Harrison Robert Gardner — Chief Information Officer
Feb 24, 2026
Sale
Shares
2,000
Price
$2.34
Total Value
$4.68K
Shares Held After
80,788
% of Holdings
2.4%
Feb 23, 2026
Sale
Shares
11,656
Price
$1.45
Total Value
$16.90K
Shares Held After
61,750
% of Holdings
15.9%
Feb 23, 2026
Sale
Shares
8,541
Price
$1.45
Total Value
$12.38K
Shares Held After
88,188
% of Holdings
8.8%
Feb 23, 2026
Purchase
Shares
550,458
Price
$5.45
Total Value
$3.00M
Shares Held After
2,763,527
% of Holdings
19.9%

Vera Therapeutics, Inc. (VERA)

Skelton Laurence Matthew — Chief Commercial Officer
Feb 23, 2026
Sale
Shares
1,582
Price
$41.98
Total Value
$66.42K
Shares Held After
64,218
% of Holdings
2.4%

Vera Therapeutics, Inc. (VERA)

Brenner Robert — Chief Medical Officer
Feb 23, 2026
Sale
Shares
2,151
Price
$41.98
Total Value
$90.31K
Shares Held After
50,947
% of Holdings
4.1%

Vera Therapeutics, Inc. (VERA)

Grant Sean — CHIEF FINANCIAL OFFICER
Feb 23, 2026
Sale
Shares
4,949
Price
$41.98
Total Value
$207.78K
Shares Held After
114,181
% of Holdings
4.2%

Vera Therapeutics, Inc. (VERA)

Turner William D. — Chief Regulatory Officer
Feb 23, 2026
Sale
Shares
2,187
Price
$41.98
Total Value
$91.82K
Shares Held After
45,313
% of Holdings
4.6%

Vera Therapeutics, Inc. (VERA)

JOHNSON DAVID LEE — Chief Operating Officer
Feb 23, 2026
Sale
Shares
2,579
Price
$41.98
Total Value
$108.28K
Shares Held After
45,727
% of Holdings
5.3%
Version: v26.3.33